Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
5.06
-0.10 (-1.94%)
At close: Mar 20, 2026, 4:00 PM EDT
5.15
+0.09 (1.78%)
After-hours: Mar 20, 2026, 5:41 PM EDT
Profound Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Profound Medical stock has a target of 12, which predicts a 137.15% increase from the current stock price of 5.06.
Price Target: $12 (+137.15%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 7, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Profound Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +137.15% | Jan 7, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +117.39% | Apr 23, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $9 → $12 | Hold → Strong Buy | Upgrades | $9 → $12 | +137.15% | Jul 16, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +113.44% | Mar 11, 2024 |
| Stifel | Stifel | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +77.87% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
34.68M
from 16.10M
Increased by 115.41%
Revenue Next Year
55.70M
from 34.68M
Increased by 60.63%
EPS This Year
-1.08
from -1.41
EPS Next Year
-0.69
from -1.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 38.7M | 62.8M | |||
| Avg | 34.7M | 55.7M | |||
| Low | 28.9M | 49.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 140.7% | 81.1% | |||
| Avg | 115.4% | 60.6% | |||
| Low | 79.6% | 42.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.90 | -0.63 | |||
| Avg | -1.08 | -0.69 | |||
| Low | -1.27 | -0.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.